Approved Study Database

Ref. No. Scientific Title Principal investigator
2025.495 Comparison of clinical, pathological, immunological, and prognostic characteristics in patients with metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and hepatitis B virus-related hepatocellular carcinoma who underwent hepatectomy: a multicenter study Dr Wong Vincent
黃煒燊
2025.373 A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Prof. YEO Winnie
2025.381 A multicenter study on the clinicopathological and genetic features of myeloid neoplasms with isochromosome 17q Dr. Cheung Joyce Sin
2025.364 A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY) Prof. HUI David Shu Cheong
2025.363 Epidemiological analytics in the realm of big data for the enhancement of the understanding of orthopaedic conditions Prof. LUI Pauline Po Yee
2025.361 Medication adherence patterns and treatment beliefs of patients using proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) Dr. TSANG Chiu Chi
2025.360 Establishment of New Territories East Cluster Biliary Tract Cancer Database Prof. CHAN Stephen Lam
2025.395 An Automatic Surgical Planning Assistant for Reverse Shoulder Arthroplasty Using Large Language Models Prof. CHUI Elvis Chun Sing
Elvis Chun-Sing Chui
2025.346 The 2023 ACR/ EULAR Classification Criteria for the thromboembolic antiphospholipid syndrome: a validation study in Hong Kong Chinese patients Dr. TANG Hoi San
鄧凱珊
2025.345 The 2023 ACR/ EULAR Classification Criteria for the thromboembolic antiphospholipid syndrome: a validation study in Hong Kong Chinese patients Prof. SO Ho
蘇皓
2025.344 The 2023 ACR/ EULAR Classification Criteria for the thromboembolic antiphospholipid syndrome: a validation study in Hong Kong Chinese patients Dr. HO Ling Yin
何令妍
2025.348 Understanding Mental Health Screening for Caregivers of Children with Developmental Concerns: Perspectives and Barriers Among Caregivers and Healthcare Providers Across Global Contexts Dr. WONG Wing Ho
2025.444 Clinical utility of cerebrospinal fluid cell-free DNA/RNA for diagnosis of leptomeningeal metastasis of non-small cell lung cancer Dr. LEUNG Joyce May Sum
2025.349 Spatial multi-omics analysis of tumor-infiltrating regulatory B cells in ovarian cancer with lymphotoxin overexpression in ovarian cancer typing diagnosis and recurrence prediction Prof. WANG Ronald
黃志超
2025.339 Lung Cancer Biomarker: Methylation Risk Score for Early Detection and Minimal Residual Disease Monitoring Dr. LI Siu Ching
2025.438 Optimising Postnatal Outcomes: Implementing the NuViva Programme Prof. POON Liona Chiu Yee
潘昭頤
2025.338 Development of a Neurofeedback System to Support Emotion Visualization Dr. WANG Yang
2025.337 Primary Obesity Surgery Endoluminal 2.0 (POSE-2) Procedure for Treatment of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease Dr. NG STEPHEN KA KEI
吳家琦
2025.320 Radiation-free Assessment of Skeletal Maturity and Bone Health Status in Paediatric Spinal Deformity Dr. LAU Adam Yiu Chung
2025.321 Organoids derived from EUS-guided tissue sampling for precision oncology in advanced pancreatic ductal adenocarcinoma Dr. XIA Xianfeng
2025.430 Validation Study of Cuffless Blood Pressure Monitoring Using Multi-Wavelength PPG and Single-Lead ECG Prof. TSOI Kelvin
2025.336 Validation of the Hong Kong Database of Emotional Face (HKDEF) Dr. WONG Wing Ho
2025.350 The Development of an Intelligent System for Real-time Automated Anatomical Recognition System During Endoscopic Ultrasound Prof. CHAN Shannon
2025.324 Establishment of Hong Kong Diabesity Register and a 3-year Randomized Clinical Trial for the Investigation of the Effectiveness of a Multicomponent Integrated Care Program in Chinese with Diabesity Prof. KONG Alice Pik Shan
2025.319 App-assisted implementation of evidence-based management of acute intracerebral haemorrhage Dr. IP Bonaventure Yiu Ming
葉耀明
2025.356 Development for AI-Powered Nasal Cavity Reconstruction Prof. TONG Michael C.F.
2025.351 Long-term effects and healthcare costs of extreme heat on cardiovascular complications in Chinese patients with type 2 diabetes Dr. LAU Siu Him
2025.316 Can biologic DMARD use retard syndesmophytes and facet joint arthritis progression and resolve axial inflammatory in psoriatic arthritis? A prospective follow up study using low-dose computed tomography and magnetic resonance imaging Prof. TAM Lai Shan
2025.352 Review of hip fracture patients with history of fragility fracture Dr. FUNG Kwun Ping
2025.358 Investigating the Predictive Power of Coronary Plaque for Major Adverse Cardiovascular Events (MACE) in Psoriatic Arthritis: A 10-year Retrospective Study Prof. TAM Lai Shan
2025.335 Butyrate and Taurine to reduce chronic postsurgical pain in adult cardiac surgical patients: a Bayesian Optimized double-blinded randomized controlled trial Dr. WONG Man Kin
2025.331 Effectiveness of a Game-based educational workshop on Hong Kong students’ change in self-efficacy, awareness, and attitudes to drug abuse Prof. LI William Ho Cheung
2025.353 An in-vitro study to examine the activity of Avibactam-aztreonam against Carbapenem resistant gram-negative bacilli in a tertiary referral laboratory in Hong Kong Dr. LAI Christopher Koon Chi
2025.330 Effectiveness of Virtual Reality-enhanced Interventions on Preoperative Anxiety in Adults Undergoing Elective Surgery: A 3-arm randomised controlled trial (VIPA trial) Mr. CHAN Sin Lun
2025.359 A two-part phase 1 open-label safety and pharmacokinetic study of intravenous RC220 in combination with doxorubicin in adult patients with solid tumours Dr. LOONG Herbert Ho Fung
2025.304 Voice Link 2.0 AI Speech Recognition Investigation Dr. FONG Raymond
2025.303 Voice Link 2.0 AI Speech Recognition Investigation Dr. CHAN Edwin Ho Yin
2025.355 Retrospective Study Protocol – Data collection for AutoTV and AutoView Prof. LEE Alex Pui Wai
李沛威
2025.322 Development and validation of a new scale to assess sexual problems in people with prostate cancer and to design an electronic patient-reported outcome measure for this population (ePROM-SexPCare) Prof. NG Chi Fai
2025.329 The effects of theory-guided multimodal educational (TIME) programme on the faecal occult blood test (FOBT) uptake rates among adults at average-risk of colorectal cancer: A randomized controlled trial Ms. KWAN Siu Kuen
2025.310 Systemic absorption of oral vancomycin: prevalence, risk factors, and clinical implications Prof. SZETO Cheuk Chun
Cheuk Chun Szeto
2025.315 The Chinese University of Hong Kong Myasthenia Gravis Registry (CUHKMGR) Dr. CHOI Joseph Chun Ho
2025.311 A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants with Elevated Lipoprotein(a) Prof. YAN Bryan Ping Yen
甄秉言
2025.305 Retrospective Review on the Management of Diabetic Ketoacidosis in the Intensive Care Unit Dr. HO Lap Tin
2025.323 Pilot Study on Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer Prof. TEOH Jeremy Yuen Chun
2025.309 A portable “sample to answer” microfluidic system for rapid detection of bacterial pathogens using nucleic acid analysis Prof. LING Lowell
2025.314 Psychological Distress and its Predictive Factors among Parents of Sick Children Dr. HO Long Kwan
2025.317 Effectiveness of a Mindfulness-Oriented Respiratory Distress Symptom Intervention for Patients with Lung Cancer and Its Association with Brain Activity Changes Dr. LOONG Herbert Ho Fung
2025.343 Development for AI-Powered Retrograde Intrarenal Surgery Prof. NG Chi Fai
2025.308 A Phase 3, Open Label, Multicenter, Randomized Study of First Line Tarlatamab in combination with Durvalumab, Carboplatin and Etoposide versus Durvalumab, Carboplatin and Etoposide in Untreated Extensive Stage Small-Cell Lung Cancer (DeLLphi-312) Dr. LOONG Herbert Ho Fung

Page 3 of 268.